awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36926668-EE48EFB9-9138-4936-8134-6FABB074953D
Q36926668-EE48EFB9-9138-4936-8134-6FABB074953D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36926668-EE48EFB9-9138-4936-8134-6FABB074953D
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules
P2860
Q36926668-EE48EFB9-9138-4936-8134-6FABB074953D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36926668-EE48EFB9-9138-4936-8134-6FABB074953D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94fdcf8a719a37612c844a812d1ab2856e6f2079
P2860
Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the random